Cargando…
Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction
PURPOSE: The purpose of this study was to report our initial experience of hyaluronic acid gel injection (HGI) in the vesicovaginal septum (VVS) for bladder dose reduction in brachytherapy (BT) for uterine cervical carcinoma. MATERIAL AND METHODS: Between September 2016 and May 2018, 15 uterine cerv...
Autores principales: | Murakami, Naoya, Shima, Satoshi, Kashihara, Tairo, Tselis, Nikolaos, Kato, Tomoyasu, Takagawa, Yoshiaki, Masui, Koji, Yoshida, Ken, Takahashi, Kana, Inaba, Koji, Okuma, Kae, Igaki, Hiroshi, Nakayama, Yuko, Itami, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431109/ https://www.ncbi.nlm.nih.gov/pubmed/30911303 http://dx.doi.org/10.5114/jcb.2019.82612 |
Ejemplares similares
-
Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience
por: Kashihara, Tairo, et al.
Publicado: (2019) -
Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies
por: Murakami, Naoya, et al.
Publicado: (2022) -
Artificial ascites for organs at risk sparing in intrapelvic
brachytherapy: a case report of recurrent uterine cervical carcinoma adjacent to
the bowel
por: Murakami, Naoya, et al.
Publicado: (2018) -
Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer
por: Kobayashi, Rei, et al.
Publicado: (2022) -
Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic
por: Murakami, Naoya, et al.
Publicado: (2021)